Edwards Lifesciences Corp (EW) 152.16 $EW
Edwards Announces Board Change
PR Newswire - Thu Jul 30, 3:01PM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that Robert A. Ingram has retired from the company's Board of Directors.
EW: 152.16 (-0.94)
St. Jude Buying Thoratec Could Resusitate Medtech M&As
at The Street - Thu Jul 30, 8:52AM CDT
Last year was big for medical device mergers and things could be heating up again this year.
ZMH: 113.56 (+0.29), BSX: 17.34 (+0.09), JNJ: 100.21 (+0.37), ABT: 50.69 (-0.08), BDX: 152.15 (+0.15), MDT: 78.39 (+0.11), STJ: 73.82 (-0.09), EW: 152.16 (-0.94), THOR: 63.29 (unch), HTWR: 90.71 (+1.98)
Abiomed Close To New Buy Point Ahead Of Q1 Earnings
at Investor's Business Daily - Wed Jul 29, 5:50PM CDT
Heart-pump maker Abiomed has added a handle to its latest base, carving out a buy point at 76.70. Shares have held up well during recent market turmoil and are about 1% off an all-time high. Abiomed (ABMD) is part of the highly rated medical products...
MNK: 123.96 (+2.26), ABMD: 77.46 (+0.20), EW: 152.16 (-0.94), PRAH: 41.99 (-0.13)
17.3% Return Seen to Date on SmarTrend Edwards Lifesciences Call (EW)
Comtex SmarTrend(R) - Wed Jul 29, 9:26AM CDT
SmarTrend identified an Uptrend for Edwards Lifesciences (NYSE:EW) on June 9th, 2015 at $133.64. In approximately 2 months, Edwards Lifesciences has returned 17.30% as of today's recent price of $156.76.
EW: 152.16 (-0.94)
Edwards Lifesciences Beats Earnings, Sales; EPS View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 29, 8:50AM CDT
Edwards Lifesciences (EW) delivered promising second-quarter 2015 financial numbers
IRMD: 24.80 (+2.44), RTIX: 7.28 (+0.47), LDRH: 45.46 (+1.29), EW: 152.16 (-0.94)
Edwards Lifesciences (EW) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Wed Jul 29, 8:12AM CDT
The following Edwards Lifesciences (EW) conference call took place on July 28, 2015, 05:00 PM ET. This is a transcript of that earnings call:
EW: 152.16 (-0.94)
Edwards Lifesciences beats
at Investor's Business Daily - Tue Jul 28, 5:42PM CDT
The heart-valve maker topped Q2 views as earnings ex items grew 28% to $1.13, 8 cents above projections, and revenue rose 6.9% to $616.8 mil, as analysts anticipated $605 mil. Edwards Lifesciences (EW) said that its transcatheter business grew 28.1%...
EW: 152.16 (-0.94)
Edwards Keeps Earnings Streak Alive With Q2 Beat
at Investor's Business Daily - Tue Jul 28, 4:05PM CDT
Edwards Lifesciences (EW) late Tuesday beat second-quarter earnings estimates, keeping alive a streak that has lasted more than two years. The heart-valve maker said second-quarter earnings per share minus items rose 28% from the year-earlier quarter...
EW: 152.16 (-0.94)
Edwards Lifesciences beats Street 2Q forecasts
Automated Insights - Tue Jul 28, 3:12PM CDT
IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Tuesday reported second-quarter net income of $112.7 million.
EW: 152.16 (-0.94)
Edwards Lifesciences Reports Second Quarter Results
PR Newswire - Tue Jul 28, 3:01PM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended June 30, 2015 of $112.7 million, or $1.02 per diluted share. Adjusted net income on a non-GAAP basis was $124.4 million, or $1.13 per diluted share, compared to $0.88 per diluted share in the prior year period. In the year ago period, GAAP net income was $5.09 per diluted share, which included a $750 million payment to Edwards from a litigation settlement.
EW: 152.16 (-0.94)
Stocks Push Ahead In Late Trade; Jazz Clears Buy Point
at Investor's Business Daily - Tue Jul 28, 2:05PM CDT
Stocks further perked up late Tuesday and were on track to end a five-session slide. All three of the major indexes have already recovered all of Monday's losses and then some. Helped by mining and energy stocks, the S&P 500 surged 1.3%. The Dow...
BDX: 152.15 (+0.15), ELLI: 78.45 (+9.32), PNRA: 204.12 (-0.36), AKAM: 76.71 (+1.75), EW: 152.16 (-0.94), SPWR: 27.03 (-1.36), BWLD: 195.58 (+0.39), MAS: 26.39 (-0.01), CTXS: 75.61 (-0.15), MTSI: 33.71 (+0.25), GILD: 117.86 (-0.04), JAZZ: 192.24 (+1.86), YELP: 26.40 (+0.37), TWTR: 31.01 (-0.46), RGR: 60.02 (-0.13)
The Best Stocks in Medical Devices Are Kicking It Overseas
Cheryl Swanson, The Motley Fool - Motley Fool - Tue Jul 28, 12:27PM CDT
Source: Flickr/Anders Sandher. Looking for medical-device stocks with solid fundamentals and long-term growth drivers? Then train your eyes overseas. With apologies to Shakespeare, the world is the medical-device industry's new oyster. While...
MDT: 78.39 (+0.11), EW: 152.16 (-0.94)
5 Health Care Stocks to Trade for Gains -- Must-See Charts
at The Street - Tue Jul 28, 12:13PM CDT
Health care stocks have been persistent outperformers in 2015. Here are five to trade now.
GILD: 117.86 (-0.04), UTHR: 169.36 (+6.57), SHPG: 266.81 (+4.29), EW: 152.16 (-0.94), IDXX: 72.73 (+1.39)
Edwards Lifesciences Set to Possibly Rebound After Yesterday's Selloff of 1.53%
Comtex SmarTrend(R) - Mon Jul 27, 5:15PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $151.90 to a high of $154.75. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $154.70 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EW: 152.16 (-0.94)
Meet 5 IBD 50 Stocks Reporting Earnings This Week
at Investor's Business Daily - Sat Jul 25, 9:02AM CDT
Earnings season has kicked into high gear, and a number of top-rated stocks such as Vasco Data Security (VDSI) and Facebook (FB) are due to report earnings this coming week. The computer-generated IBD 50 list of premier stocks is based on a...
VDSI: 20.39 (-0.78), ELLI: 78.45 (+9.32), GILD: 117.86 (-0.04), FB: 94.01 (-1.20), ORLY: 240.31 (+2.16), UTHR: 169.36 (+6.57), EW: 152.16 (-0.94), CRI: 101.41 (+0.99), TASR: 27.22 (-0.89)
Valeant, Starbucks Lead 5 IBD 50 Stocks Bucking Market
at Investor's Business Daily - Fri Jul 24, 6:14PM CDT
A handful of IBD 50 stocks got a boost last week, bucking overall market weakness, thanks to better-than-expected quarterly results. Illumina (ILMN), which makes genetic testing equipment, was among the few disappointments. It plunged 8% Wednesday...
VRX: 257.53 (+3.25), ELLI: 78.45 (+9.32), FB: 94.01 (-1.20), UHS: 145.23 (+3.79), UTHR: 169.36 (+6.57), ORLY: 240.31 (+2.16), EW: 152.16 (-0.94), ILMN: 219.30 (+0.43), MANH: 64.82 (-0.26), SBUX: 57.93 (-0.13), VDSI: 20.39 (-0.78), CRUS: 33.01 (-0.40), TASR: 27.22 (-0.89), AAPL: 121.30 (-1.07)
New Cardiac Devices Get Investors' Hearts Pumping
at Investor's Business Daily - Fri Jul 24, 2:16PM CDT
A hot new technology. A widespread, deadly disease. A whole lot of money changing hands. That was the story last Wednesday when St. Jude Medical (STJ) agreed to pay $3.4 billion in cash for Thoratec (THOR), developer of an implant called the left...
BSX: 17.34 (+0.09), ABT: 50.69 (-0.08), ABMD: 77.46 (+0.20), MDT: 78.39 (+0.11), CAH: 84.98 (+1.64), LMAT: 14.24 (+0.84), EW: 152.16 (-0.94), STJ: 73.82 (-0.09), THOR: 63.29 (unch), VASC: 37.23 (+0.03), HTWR: 90.71 (+1.98), MMSI: 25.56 (+0.39)
The World Market for Catheters (Urological, Intravenous, Cardiovascular Intervention, Angiography, Dialysis, PTCA, PICC, Oximetry and Surgical Catheters) to 2019
M2 - Fri Jul 24, 8:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v8qwd2/the_world_market) has announced the addition of the "The World Market for Catheters (Urological, Intravenous, Cardiovascular Intervention, Angiography, Dialysis, PTCA, PICC, Oximetry and Surgical Catheters)" report to their offering. Among the catheters used in urological applications are the Foley and the urethral catheters. Cardiovascular catheters find use in cardiac catheterization. Angiography catheters are used in cardiological diagnostics. Intravenous catheters are used if a person requires frequent or continuous injections of medications or fluids for nutritional support. A wound drain catheter is inserted while a patient is in the operating room receiving general anesthesia All of these catheters are included in this report. For many of these segments, company market share and regional breakout for US, Europe and Rest of World is provided. In addition to numbers that can be useful for business planning, the report provides analysis of the industry, including analysis of several important trends. Increased life expectancy and subsequent aging of the global population play a key role in the rising demand for all types of medical catheters. Companies seeking opportunities in this medical device market will want to utilize Kalorama Information's World Market for Catheters. This report contains global market size and forecast to 2019 for the following types of catheters: - Foley Catheters - Urethral Catheters - PTCA Catheters - Dialysis Catheters - Atherectomy Catheters - Ablation Catheters - Cardiac Angiography Catheters - Peripheral Angiography Catheters - Implantable Ports - Central Venous Catheters - Peripheral Insertion Catheters - Peripherally Inserted Central Catheters - Peripheral Insertion Midline Catheters - Oximetry Catheters - Thermodilution Catheters - Suction Catheters - Wound Drainage Catheters Trends discussed in this report include the following: - Infection and Control - Vascular - Urinary - Catheter Intervention Trends - Catheter Malfunction - Antimicrobial Lock Solutions - Stroke Treatment - MRI Catheters - Sinus Balloon Catheter - Interventional Radiology - Heart Patch - PFO - New And Alternative Materials - Antiseptic-Coated Catheters Company profiles are included, with profiles of the following companies: - Abbott Laboratories - Angio Dynamics - Atrium Medical - Bactiguard Ab - C.R. Bard - Becton Dickinson - Boston Scientific - B. Braun Melsungen - Cardinal Health - Carmeda - Cook Group - Catheter Research Inc. - Covidien - Edwards Lifesciences - Greatbatch Medical - Johnson &Johnson - Flexicath - Hansen Medical - Iapyx Medical - Integra Lifesciences Holdings - Irvine Scientific - Medtronic - Medcomp - Siemens Medical Solutions - Smiths Medical - St.Jude Medical - Teleflex Medical Company - Terumo - Vascular Solutions - Vesta Inc. - Volcano Corp. - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/v8...rld_market
ZMH: 113.56 (+0.29), BSX: 17.34 (+0.09), ABT: 50.69 (-0.08), MDT: 78.39 (+0.11), HNSN: 0.85 (+0.01), VOLC: 17.99 (+0.01), EW: 152.16 (-0.94), VASC: 37.23 (+0.03)
What's in Store for Edwards Lifesciences (EW) in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 23, 5:14PM CDT
Last quarter, Edwards Lifesciences (EW) had delivered a positive earnings surprise of 7.69%
ZLTQ: 34.35 (+2.24), EW: 152.16 (-0.94), AMED: 43.63 (+0.88), XRAY: 56.91 (+0.85)
Breakout Watch: Abiomed Pumps Up Before Earnings
at Investor's Business Daily - Thu Jul 23, 10:39AM CDT
Heart pump maker Abiomed (ABMD) is closing in on a buy point as it gets ready to report Q2 earnings Aug. 4. With a mission of "recovering hearts and saving lives," Abiomed developed the Impella 2.5, which it bills as the world's smallest heart pump....
ABMD: 77.46 (+0.20), MDT: 78.39 (+0.11), STJ: 73.82 (-0.09), EW: 152.16 (-0.94), THOR: 63.29 (unch)
Edwards Announces Board Change
PR Newswire - Thu Jul 30, 3:01PM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that Robert A. Ingram has retired from the company's Board of Directors.
EW: 152.16 (-0.94)
St. Jude Buying Thoratec Could Resusitate Medtech M&As
at The Street - Thu Jul 30, 8:52AM CDT
Last year was big for medical device mergers and things could be heating up again this year.
ZMH: 113.56 (+0.29), BSX: 17.34 (+0.09), JNJ: 100.21 (+0.37), ABT: 50.69 (-0.08), BDX: 152.15 (+0.15), MDT: 78.39 (+0.11), STJ: 73.82 (-0.09), EW: 152.16 (-0.94), THOR: 63.29 (unch), HTWR: 90.71 (+1.98)
Abiomed Close To New Buy Point Ahead Of Q1 Earnings
at Investor's Business Daily - Wed Jul 29, 5:50PM CDT
Heart-pump maker Abiomed has added a handle to its latest base, carving out a buy point at 76.70. Shares have held up well during recent market turmoil and are about 1% off an all-time high. Abiomed (ABMD) is part of the highly rated medical products...
MNK: 123.96 (+2.26), ABMD: 77.46 (+0.20), EW: 152.16 (-0.94), PRAH: 41.99 (-0.13)
17.3% Return Seen to Date on SmarTrend Edwards Lifesciences Call (EW)
Comtex SmarTrend(R) - Wed Jul 29, 9:26AM CDT
SmarTrend identified an Uptrend for Edwards Lifesciences (NYSE:EW) on June 9th, 2015 at $133.64. In approximately 2 months, Edwards Lifesciences has returned 17.30% as of today's recent price of $156.76.
EW: 152.16 (-0.94)
Edwards Lifesciences Beats Earnings, Sales; EPS View Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 29, 8:50AM CDT
Edwards Lifesciences (EW) delivered promising second-quarter 2015 financial numbers
IRMD: 24.80 (+2.44), RTIX: 7.28 (+0.47), LDRH: 45.46 (+1.29), EW: 152.16 (-0.94)
Edwards Lifesciences (EW) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Wed Jul 29, 8:12AM CDT
The following Edwards Lifesciences (EW) conference call took place on July 28, 2015, 05:00 PM ET. This is a transcript of that earnings call:
EW: 152.16 (-0.94)
Edwards Lifesciences beats
at Investor's Business Daily - Tue Jul 28, 5:42PM CDT
The heart-valve maker topped Q2 views as earnings ex items grew 28% to $1.13, 8 cents above projections, and revenue rose 6.9% to $616.8 mil, as analysts anticipated $605 mil. Edwards Lifesciences (EW) said that its transcatheter business grew 28.1%...
EW: 152.16 (-0.94)
Edwards Keeps Earnings Streak Alive With Q2 Beat
at Investor's Business Daily - Tue Jul 28, 4:05PM CDT
Edwards Lifesciences (EW) late Tuesday beat second-quarter earnings estimates, keeping alive a streak that has lasted more than two years. The heart-valve maker said second-quarter earnings per share minus items rose 28% from the year-earlier quarter...
EW: 152.16 (-0.94)
Edwards Lifesciences beats Street 2Q forecasts
Automated Insights - Tue Jul 28, 3:12PM CDT
IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Tuesday reported second-quarter net income of $112.7 million.
EW: 152.16 (-0.94)
Edwards Lifesciences Reports Second Quarter Results
PR Newswire - Tue Jul 28, 3:01PM CDT
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended June 30, 2015 of $112.7 million, or $1.02 per diluted share. Adjusted net income on a non-GAAP basis was $124.4 million, or $1.13 per diluted share, compared to $0.88 per diluted share in the prior year period. In the year ago period, GAAP net income was $5.09 per diluted share, which included a $750 million payment to Edwards from a litigation settlement.
EW: 152.16 (-0.94)
Stocks Push Ahead In Late Trade; Jazz Clears Buy Point
at Investor's Business Daily - Tue Jul 28, 2:05PM CDT
Stocks further perked up late Tuesday and were on track to end a five-session slide. All three of the major indexes have already recovered all of Monday's losses and then some. Helped by mining and energy stocks, the S&P 500 surged 1.3%. The Dow...
BDX: 152.15 (+0.15), ELLI: 78.45 (+9.32), PNRA: 204.12 (-0.36), AKAM: 76.71 (+1.75), EW: 152.16 (-0.94), SPWR: 27.03 (-1.36), BWLD: 195.58 (+0.39), MAS: 26.39 (-0.01), CTXS: 75.61 (-0.15), MTSI: 33.71 (+0.25), GILD: 117.86 (-0.04), JAZZ: 192.24 (+1.86), YELP: 26.40 (+0.37), TWTR: 31.01 (-0.46), RGR: 60.02 (-0.13)
The Best Stocks in Medical Devices Are Kicking It Overseas
Cheryl Swanson, The Motley Fool - Motley Fool - Tue Jul 28, 12:27PM CDT
Source: Flickr/Anders Sandher. Looking for medical-device stocks with solid fundamentals and long-term growth drivers? Then train your eyes overseas. With apologies to Shakespeare, the world is the medical-device industry's new oyster. While...
MDT: 78.39 (+0.11), EW: 152.16 (-0.94)
5 Health Care Stocks to Trade for Gains -- Must-See Charts
at The Street - Tue Jul 28, 12:13PM CDT
Health care stocks have been persistent outperformers in 2015. Here are five to trade now.
GILD: 117.86 (-0.04), UTHR: 169.36 (+6.57), SHPG: 266.81 (+4.29), EW: 152.16 (-0.94), IDXX: 72.73 (+1.39)
Edwards Lifesciences Set to Possibly Rebound After Yesterday's Selloff of 1.53%
Comtex SmarTrend(R) - Mon Jul 27, 5:15PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $151.90 to a high of $154.75. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $154.70 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
EW: 152.16 (-0.94)
Meet 5 IBD 50 Stocks Reporting Earnings This Week
at Investor's Business Daily - Sat Jul 25, 9:02AM CDT
Earnings season has kicked into high gear, and a number of top-rated stocks such as Vasco Data Security (VDSI) and Facebook (FB) are due to report earnings this coming week. The computer-generated IBD 50 list of premier stocks is based on a...
VDSI: 20.39 (-0.78), ELLI: 78.45 (+9.32), GILD: 117.86 (-0.04), FB: 94.01 (-1.20), ORLY: 240.31 (+2.16), UTHR: 169.36 (+6.57), EW: 152.16 (-0.94), CRI: 101.41 (+0.99), TASR: 27.22 (-0.89)
Valeant, Starbucks Lead 5 IBD 50 Stocks Bucking Market
at Investor's Business Daily - Fri Jul 24, 6:14PM CDT
A handful of IBD 50 stocks got a boost last week, bucking overall market weakness, thanks to better-than-expected quarterly results. Illumina (ILMN), which makes genetic testing equipment, was among the few disappointments. It plunged 8% Wednesday...
VRX: 257.53 (+3.25), ELLI: 78.45 (+9.32), FB: 94.01 (-1.20), UHS: 145.23 (+3.79), UTHR: 169.36 (+6.57), ORLY: 240.31 (+2.16), EW: 152.16 (-0.94), ILMN: 219.30 (+0.43), MANH: 64.82 (-0.26), SBUX: 57.93 (-0.13), VDSI: 20.39 (-0.78), CRUS: 33.01 (-0.40), TASR: 27.22 (-0.89), AAPL: 121.30 (-1.07)
New Cardiac Devices Get Investors' Hearts Pumping
at Investor's Business Daily - Fri Jul 24, 2:16PM CDT
A hot new technology. A widespread, deadly disease. A whole lot of money changing hands. That was the story last Wednesday when St. Jude Medical (STJ) agreed to pay $3.4 billion in cash for Thoratec (THOR), developer of an implant called the left...
BSX: 17.34 (+0.09), ABT: 50.69 (-0.08), ABMD: 77.46 (+0.20), MDT: 78.39 (+0.11), CAH: 84.98 (+1.64), LMAT: 14.24 (+0.84), EW: 152.16 (-0.94), STJ: 73.82 (-0.09), THOR: 63.29 (unch), VASC: 37.23 (+0.03), HTWR: 90.71 (+1.98), MMSI: 25.56 (+0.39)
The World Market for Catheters (Urological, Intravenous, Cardiovascular Intervention, Angiography, Dialysis, PTCA, PICC, Oximetry and Surgical Catheters) to 2019
M2 - Fri Jul 24, 8:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v8qwd2/the_world_market) has announced the addition of the "The World Market for Catheters (Urological, Intravenous, Cardiovascular Intervention, Angiography, Dialysis, PTCA, PICC, Oximetry and Surgical Catheters)" report to their offering. Among the catheters used in urological applications are the Foley and the urethral catheters. Cardiovascular catheters find use in cardiac catheterization. Angiography catheters are used in cardiological diagnostics. Intravenous catheters are used if a person requires frequent or continuous injections of medications or fluids for nutritional support. A wound drain catheter is inserted while a patient is in the operating room receiving general anesthesia All of these catheters are included in this report. For many of these segments, company market share and regional breakout for US, Europe and Rest of World is provided. In addition to numbers that can be useful for business planning, the report provides analysis of the industry, including analysis of several important trends. Increased life expectancy and subsequent aging of the global population play a key role in the rising demand for all types of medical catheters. Companies seeking opportunities in this medical device market will want to utilize Kalorama Information's World Market for Catheters. This report contains global market size and forecast to 2019 for the following types of catheters: - Foley Catheters - Urethral Catheters - PTCA Catheters - Dialysis Catheters - Atherectomy Catheters - Ablation Catheters - Cardiac Angiography Catheters - Peripheral Angiography Catheters - Implantable Ports - Central Venous Catheters - Peripheral Insertion Catheters - Peripherally Inserted Central Catheters - Peripheral Insertion Midline Catheters - Oximetry Catheters - Thermodilution Catheters - Suction Catheters - Wound Drainage Catheters Trends discussed in this report include the following: - Infection and Control - Vascular - Urinary - Catheter Intervention Trends - Catheter Malfunction - Antimicrobial Lock Solutions - Stroke Treatment - MRI Catheters - Sinus Balloon Catheter - Interventional Radiology - Heart Patch - PFO - New And Alternative Materials - Antiseptic-Coated Catheters Company profiles are included, with profiles of the following companies: - Abbott Laboratories - Angio Dynamics - Atrium Medical - Bactiguard Ab - C.R. Bard - Becton Dickinson - Boston Scientific - B. Braun Melsungen - Cardinal Health - Carmeda - Cook Group - Catheter Research Inc. - Covidien - Edwards Lifesciences - Greatbatch Medical - Johnson &Johnson - Flexicath - Hansen Medical - Iapyx Medical - Integra Lifesciences Holdings - Irvine Scientific - Medtronic - Medcomp - Siemens Medical Solutions - Smiths Medical - St.Jude Medical - Teleflex Medical Company - Terumo - Vascular Solutions - Vesta Inc. - Volcano Corp. - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/v8...rld_market
ZMH: 113.56 (+0.29), BSX: 17.34 (+0.09), ABT: 50.69 (-0.08), MDT: 78.39 (+0.11), HNSN: 0.85 (+0.01), VOLC: 17.99 (+0.01), EW: 152.16 (-0.94), VASC: 37.23 (+0.03)
What's in Store for Edwards Lifesciences (EW) in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 23, 5:14PM CDT
Last quarter, Edwards Lifesciences (EW) had delivered a positive earnings surprise of 7.69%
ZLTQ: 34.35 (+2.24), EW: 152.16 (-0.94), AMED: 43.63 (+0.88), XRAY: 56.91 (+0.85)
Breakout Watch: Abiomed Pumps Up Before Earnings
at Investor's Business Daily - Thu Jul 23, 10:39AM CDT
Heart pump maker Abiomed (ABMD) is closing in on a buy point as it gets ready to report Q2 earnings Aug. 4. With a mission of "recovering hearts and saving lives," Abiomed developed the Impella 2.5, which it bills as the world's smallest heart pump....
ABMD: 77.46 (+0.20), MDT: 78.39 (+0.11), STJ: 73.82 (-0.09), EW: 152.16 (-0.94), THOR: 63.29 (unch)
